Catrin M. Cox
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Identifying risk factors for venous thromboembolism in medical inpatients: a systematic review and meta-analysis.
Journal: Research and practice in thrombosis and haemostasis
Published: December 23, 2025
Prevalence and outcomes of antiphospholipid syndrome after unprovoked venous thromboembolism: a multicenter real-world data analysis.
Journal: Journal of thrombosis and haemostasis : JTH
Published: December 22, 2025
Antiphospholipid syndrome and pregnancy-a hematologic perspective.
Journal: Research and practice in thrombosis and haemostasis
Published: October 30, 2025
New approaches in the haemostatic management of postpartum haemorrhage.
Journal: BMJ medicine
Published: October 16, 2025
Basics of diagnosis and treatment of venous thromboembolism.
Journal: Journal of thrombosis and haemostasis : JTH
Published: August 23, 2024
Oxaliplatin/capecitabine or carboplatin/paclitaxel-based preoperative chemoradiation for resectable oesophageal adenocarcinoma (NeoSCOPE): Long-term results of a randomised controlled trial.
Journal: European journal of cancer (Oxford, England : 1990)
Published: February 12, 2021
Pentraxin 3 is a stromally-derived biomarker for detection of pancreatic ductal adenocarcinoma.
Journal: NPJ precision oncology
Published: October 02, 2020
Circulating biomarkers and outcomes from a randomised phase 2 trial of gemcitabine versus capecitabine-based chemoradiotherapy for pancreatic cancer.
Journal: British journal of cancer
Published: June 11, 2020
Medullary Thyroid Cancer Patient's Assessment of Quality of Life Tools: Results from the QaLM Study.
Medullary Thyroid Cancer Patient's Assessment of Quality of Life Tools: Results from the QaLM Study.
Journal: European thyroid journal
Published: December 30, 2019
Fulvestrant plus capivasertib versus placebo after relapse or progression on an aromatase inhibitor in metastatic, oestrogen receptor-positive breast cancer (FAKTION): a multicentre, randomised, controlled, phase 2 trial.
Journal: The Lancet. Oncology
Published: October 16, 2019
Showing 1-11 of 11
Last Updated: 09/26/2026